Related Experiment Video
Updated: Apr 30, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Autoimmune hepatitis: trust in transaminases
Joao Brissos1, Catarina Carrusca, Marta Correia
1Department of Pediatrics, Hospital Dona Estefania, Lisboa, Portugal.
Early diagnosis of autoimmune hepatitis in children is crucial. This case shows that unexplained elevated aminotransferases in asymptomatic children warrant investigation for early detection and treatment, improving prognosis.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Clinical Immunology
- Diagnostic Laboratory Medicine
Background:
- Liver biochemical tests are vital for diagnosing liver diseases, even in asymptomatic individuals.
- Abnormal aminotransferase levels necessitate careful evaluation to identify underlying conditions.
- Autoimmune hepatitis (AIH) is a rare liver disease characterized by significant clinical variability.
Observation:
- A previously healthy, asymptomatic child presented with incidentally discovered elevated aminotransferases.
- Initial investigations revealed hypergammaglobulinemia with elevated IgG and positive anti-liver cytosol type 1 antibodies.
- Liver biopsy confirmed severe interface hepatitis, indicative of autoimmune hepatitis.
Findings:
- The child was diagnosed with autoimmune hepatitis based on clinical, serological, and histological findings.
- Prompt initiation of immunosuppressive therapy with steroids and azathioprine led to a positive clinical response.
- The case underscores the diagnostic utility of liver function tests in pediatric populations.
Implications:
- Elevated serum aminotransferases in asymptomatic children should be thoroughly investigated.
- Early diagnosis and treatment of autoimmune hepatitis significantly improve patient outcomes.
- Clinical suspicion combined with specific serological markers and liver biopsy is key for managing pediatric autoimmune hepatitis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

